Oliver Schnell

Endocrinology, Diabetes and Metabolism · 2014–2021

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Oliver Schnell trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. G. Moneta (in Endocrinology, Diabetes and Metabolism)

Papers from Oliver Schnell's perspective

Ordered by how strongly the researchers Oliver Schnell trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). (Kidney International)
  2. Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes (New England Journal of Medicine)
  3. Effect of a multifactorial intervention on mortality in type 2 diabetes. (New England Journal of Medicine)
  4. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 (Cardiovascular Diabetology)
  5. Type 2 diabetes and incidence of a wide range of cardiovascular diseases: a cohort study in 1·9 million people. (The Lancet)
  6. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity (Circulation Research)
  7. Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes – Mechanisms, Management, and Clinical Considerations (Circulation)
  8. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. (The Lancet)
  9. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.
  10. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Their papers